Navigating a complex case of pediatric COVID-19 with immunomodulatory therapies
October 21st 2023American Academy of Pediatrics
Eculizumab and anakinra should be considered in critically ill patients with severe infections that require immunomodulating therapies for life-threatening dysregulation, according to a poster session at the 2023 American Academy of Pediatrics National Conference & Exhibition.
Nature exposure therapy for pediatric patients with chronic pain
October 20th 2023American Academy of Pediatrics
Authors of a study highlighted at the 2023 American Academy of Pediatrics National Conference & Exhibition suggest nature exposure therapy could be beneficial for pediatric with chronic pain